Global Breast Lesion Localization Methods Market Forecast and Opportunities: Current Technological Measures and Advancements

The global Breast Lesion Localization Methods market is projected to reach USD 2,369.15 million by 2029, from USD 740.02 million in 2020 and is anticipated to register a CAGR of 14.1% between 2021 and 2026.

Magnetic localization is one of the most feasible and suitable methods for localizing breast lesion. Magnetic seed are placed more accurately at the site of lesion as they do not migrate from identified location to other and are highly detectable at any depth of tissue. Using magnetic localization in combination with Sienna+ magnetic tracer for SLNs detection makes breast conserving surgery convenient and entirely independent of radioactive methods.

As of 2018, only 60% of the breast cancer patients in the developed countries have access to the technique and less than 5% population in China and other countries have access to the technology.
Over 60% of the global population is residing in Asia Pacific and more than 35% of the global population is found in just two countries India and China. As per WHO, more than 29.1 women in 100,000 are diagnosed with breast cancer in Asia Pacific region, which is significantly lower than the world's average 43 in 100,000. However, the prevalence of cancer varies country to country.

For full overview visit @ https://flairintelligence.com/global-breast-lesion-localization-methods-market-forecast-and-opportunities/
Or
Email: info@flairintelligence.com

Every year, breast cancer is affecting a large women population in China. In fact, it is the leading cause of death in women. Every year, more than 36 women in 100,000 are diagnosed with breast cancer in the country. For instance, women living in urban cities are more prone to suffer from the disease than rural areas.
With the rapid urbanization in the country, a greater number of people are migrating to the mega cities. This has further upsurged the prevalence. For small cities (population below 500,000), the incidence of breast cancer is 30 per 100,000. For medium-sized cities (population between 500,000 to 1,000,000), it is 40 in 100,000. And for large cities (population above 1million), the incidence rate is 60 per 100,000 women. This is majorly attributed to change in the stress level, changing lifestyle, and aging.

Japan and South Korea report the highest incidence rates of breast cancer for eastern Asia (51.5 and 52.1 per 100,000, respectively), whereas for south-eastern Asia the highest rate is noted in Singapore (65.7/100,000). The observed increase in breast cancer incidence rates also varies between different Asian countries, with increases of 6% per year seen in Japan.

However, most of the countries in Asia Pacific regions including India and China do not have robust healthcare infrastructure that can handle the increasing load of breast cancer. In addition to this, these countries have limited number of multispecialty hospitals having oncology department.

Out of the available oncology departments, more than 37% of them do not have required technology for the diagnosis and treatment of breast cancers. Patients often have to get the diagnosis done from the private lab. Moreover, people are highly cost-sensitive and often do not have health insurance, which make them to expend through out-of-pocket.

Office A & B, Kakade Terrace
Warje, Pune 411058
Mail: info@flairintelligence.com

Flair Intelligence is market research and consulting firm, with a vast expertise in technology and consumer goods reports. Our colossal repository of research reports, would present you with an in depth details about the market ranging from evolving trends, competitive analysis and bench marking, lucrative investment pockets, which will help your business drive profitable growth.
Our Major Services:
• Custom Research
• Industry Monitoring Services
• Syndicate Research

This release was published on openPR.